inflammatory breast cancer


Also found in: Acronyms, Wikipedia.

inflammatory breast cancer

Oncology Breast CA characterized by ↑ warmth, redness, swelling caused by cancer cells blocking skin lymphatics; skin has a pitted “peau d'orange” appearance. See Breast cancer.

Patient discussion about inflammatory breast cancer

Q. Is it the symptom of the inflammatory breast cancer, I am scared …. What do you think that this could be? Hello…… I am 27, female and I have noticed a little lump on my left breast. It is light pink in color and it irritates when touched a little. Is it the symptom of the inflammatory breast cancer, I am scared …. What do you think that this could be?

A. Do not worry! These are normal for young woman as they get pink lumps on their breast from time to time. It doesn’t looks like a symptom of the inflammatory breast cancer. It may be a cyst, swollen gland, bruise, or something else. Your one breast would be larger than the other, if it’s inflammatory breast cancer. You should go to the doctor and have breast examination to conclude your problem.

Q. Is it the symptom of the inflammatory breast cancer, I am scared … What do you think that this could be? Hello…… I am 27, female and I have noticed a little lump on my left breast. It is light pink in color and it irritates when touched a little. Is it the symptom of the inflammatory breast cancer, I am scared …. What do you think that this could be?

A. Inflammatory breast cancer usually presents as a more diffuse discoloration (usually brawny) of the skin or "orange peel" appearance. The findings you describe may represent cyst or localized infection. In addition, you're quite young, so breast cancer is not the common diagnosis of breast lumps at your age.

However, making diagnosis over the net, without even seeing you is both unreliable and inappropriate, so consulting a doctor may be wise.

Take care,

More discussions about inflammatory breast cancer
References in periodicals archive ?
For the study, Cukierman, a tumor microenvironment expert, and her colleagues in the lab of Massimo Cristofanilli, MD, Professor at Fox Chase and a leading expert in inflammatory breast cancer, used tumor-associated stromal cells from patients with advanced IBC to build a 3D structure consisting of cell-derived extracellular matrix-scaffold that provides structural and biochemical support to cells.
Is there a reliable method to assess the complete pathologic response on the tumor after neo-adjuvant chemotherapy in inflammatory breast cancer toward recommendations for the pathologic process?
This year's IOL tracks include clinical updates in neuroendocrine cancer, inflammatory breast cancer, patient care and administrative issues, survivorship/transitional care planning, navigation, nurse internships, and cultural competency.
The result showed an identification rate of 80% and false-negative rate of 18% for SLNB after neoadjuvant chemotherapy for patients with inflammatory breast cancer, and the conclusion was that SLNB was not suitable in this cohort.
Inflammatory breast cancer (IBC) represents an extremely virulent albeit low-incidence subtype of breast cancer, for which improvements in management and outcomes are urgently needed.
Event-free survival at 3 years was significantly greater among women with HER2-positive locally advanced or inflammatory breast cancer who received trastuzumab as neoadjuvant and adjuvant therapy in the international, open-label, phase III NOAH trial, investigators reported.
Carolyn was stay-at-home mother who had been diagnosed with inflammatory breast cancer, a rare but extremely aggressive tumor.
Topics include molecular analysis of genetic instability caused by chronic inflammation, inflammation-related aberrant patterns of DNA methylation, cDNA microarray analysis of inflammatory breast cancer signatures, induced nitric oxide synthase as a major player in the oncogenic transformation of inflame tissue, development of a cell-based assay to quantify the inflammatory potential of test substances and screen compound libraries for anti-cancer drug candidates in high-throughput format, quantitative measurement of cytokine expression in synoviocytes derived from rheumatoid arthritis patients, investigating macrophage and malignant cell interactions in vitro, and the molecular basis of histone deacetylase inhibitors as new drugs for the treatment of inflammatory diseases and cancer.
Why don't more mammogram technicians know about inflammatory breast cancer (IBC)?
Inflammatory breast cancer is a rare but very aggressive type of breast cancer in which the cancer cells block the lymph vessels in the skin of the breast.
Their daughter-in-law, Meighan, 39, was diagnosed with inflammatory breast cancer last spring.

Full browser ?